Kypha discovers, develops and commercializes innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. These tests have application across a wide range of indications that include: lupus, stroke, traumatic brain injury, and meningitis.

Kypha is headquartered in St. Louis, MO.


Arsenal Capital Management – St Louis | Kypha
class="pirenko_portfolios-template-default single single-pirenko_portfolios postid-166 samba_theme samba_left_nav samba_left_align samba_responsive wpb-js-composer js-comp-ver-5.1.1 vc_responsive"